Published in:
01-02-2010 | Short Communication
Serum amyloid A is a useful marker to evaluate the disease activity of Takayasu’s arteritis
Authors:
Tomohiro Koga, Yuichiro Nishino, Junya Makiyama, Takeshi Hayashida, Taichiro Miyashita, Yasumori Izumi, Mami Tamai, Atsushi Kawakami, Katsumi Eguchi, Kiysohi Migita
Published in:
Rheumatology International
|
Issue 4/2010
Login to get access
Abstract
Takayasu’s arteritis (TA) is a rare large vessel vasculitis that is difficult to diagnose in the early stages. Therefore, it is also very difficult to manage and prevent irreversible vascular damage in TA. A 19-year-old female patient with back pain was examined using [18F]-FDG-PET to detect the source of inflammation. Specific accumulation of [18F]-FDG was observed in the thoracic and abdominal aorta, leading to the diagnosis of TA. Corticosteroid treatment resulted in clinical remission. However, the serum amyloid A (SAA) levels remained elevated. A follow-up scan showed residual uptake of [18F]-FDG in the thoracic aorta suggesting subclinical vascular inflammation. Methotrexate was combined with the corticosteroid, and the elevated levels of SAA became normalized. The present case suggests that monitoring serum levels of SAA and [18F]-FDG-PET could help clinicians to make adequate treatment adjustments in TA patients.